Anhui Rencheng Technology Co., Ltd.

New news from pharmaceutical e-commerce


Affected by the new crown pneumonia epidemic, my country's chemical drug production shrank in the first half of 2020, but enterprise production and operation gradually recovered in the second half of the year. The annual chemical drug market size remained the same as the previous year, and the overall scale of raw materials and pharmaceuticals was around 1.2 trillion yuan.

From the perspective of enterprises, the leading enterprises still remain in the lead. From the perspective of regional distribution, the regions with advantages of traditional chemical medicines are ranked high. In 2020, a total of 119 products in Jiangsu Province passed the consistency evaluation and ranked first. At the same time, Zhejiang, Shandong, Anhui, and Sichuan ranked second to fifth in the number of reviews.

Among them, amlodipine besylate has over-rated 35 companies, ranking first.

There are more than 20 domestic license-out projects and 9 chemical drugs, mainly involving innovative pharmaceutical industries such as Hengrui Pharmaceuticals, Hausen Pharmaceuticals, and Rencheng Technology. Under the background of the normalization of mass procurement, the competition for popular products is becoming increasingly fierce.

Our company has always stuck to its own position, worked hard, abide by its own duty, and ensure the quality of products. It is expected to achieve domestic market advantage in the coming year. Our customers are distributed in the United States, Britain, Canada, Russia, and so on. . . Welcome everyone to visit the company/factory.

You can put forward our shortcomings, let our company speed up the pace of progress, let us win-win together, if you have any needs, please feel free to contact us.

We will gradually expand and build a team that dares to fight tough battles, excellent talents, and reserve a team that can shine at the critical moment.

Post time: Dec-02-2021